Ocular Therapeutix Stock (NASDAQ: OCUL) stock price, news, charts, stock research, profile.
Open | $8.10 |
Close | $8.00 |
Volume / Avg. | 2.29M / 2.73M |
Day Range | 7.84 - 8.45 |
52 Wk Range | 2.00 - 11.31 |
Market Cap | $1.26B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 72 |
Short Interest | 13.83% |
Days to Cover | 5.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP) and Phibro Animal Health (NASDAQ:PAHC).
There is no analysis for Ocular Therapeutix.
Ocular Therapeutix has a consensus price target of $15.50.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $8.15 last updated Today at July 17, 2024 at 4:59 PM EDT.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.